Gb Sciences Stock Today
| GBLX Stock | USD 0 0.0002 16.67% |
Performance13 of 100
| Odds Of DistressOver 67
|
GB Sciences is trading at 0.0014 as of the 4th of December 2024; that is 16.67 percent increase since the beginning of the trading day. The stock's open price was 0.0012. GB Sciences has more than 67 % chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. Equity ratings for GB Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 5th of September 2024 and ending today, the 4th of December 2024. Click here to learn more.
GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 379.21 M outstanding shares. More on GB Sciences
Moving together with GBLX Pink Sheet
| 0.8 | NVO | Novo Nordisk AS | PairCorr |
| 0.79 | NONOF | Novo Nordisk AS | PairCorr |
| 0.77 | CSLLY | CSL | PairCorr |
| 0.62 | CMXHF | CSL Limited | PairCorr |
| 0.84 | REGN | Regeneron Pharmaceuticals | PairCorr |
Moving against GBLX Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
GBLX Pink Sheet Highlights
| President, CFO and COO | John Poss |
| Thematic Idea | Marijuana (View all Themes) |
| Business Concentration | Marijuana, Biotechnology, Healthcare (View all Sectors) |
GB Sciences [GBLX] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.21 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate GB Sciences's market, we take the total number of its shares issued and multiply it by GB Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. GB Sciences conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 379.21 M outstanding shares.
GB Sciences currently holds about 53.96 K in cash with (1.87 M) of positive cash flow from operations.
Check GB Sciences Probability Of Bankruptcy
Ownership AllocationGB Sciences secures a total of 379.21 Million outstanding shares. GB Sciences owns 13.08 % of its outstanding shares held by insiders and 0.0 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.
Check GBLX Ownership Details
GB Sciences Risk Profiles
| Mean Deviation | 150.76 | |||
| Semi Deviation | 20.76 | |||
| Standard Deviation | 604.1 | |||
| Variance | 364931.84 |
GBLX Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in GB Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
GB Sciences Corporate Management
| Krin Kuethe | VP Cultivation | Profile | |
| Gary Esq | Securities Sec | Profile | |
| Zach Swarts | Chief CFO | Profile | |
| MBA MBA | Chief Board | Profile |
Additional Tools for GBLX Pink Sheet Analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.